A Phase 2, Open-Label, Multi-Dose, Dose Escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous Infusions of ALN-TTR02 in Patients With TTR Amyloidosis
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008232/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This was a multiple dose, dose escalation study designed to determine the safety,
tolerability, pharmacokinetics and pharmacodynamics of patisiran (ALN-TTR02) in participants
with transthyretin (TTR) mediated amyloidosis (ATTR).
提供机构：
Vivli
创建时间：
2022-07-06
